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Abstract
Nonribosomally and ribosomally synthesized bioactive peptides constitute a source of molecules of great biomedical
importance, including antibiotics such as penicillin, immunosuppressants such as cyclosporine, and cytostatics such as
bleomycin. Recently, an innovative mass-spectrometry-based strategy, peptidogenomics, has been pioneered to effectively
mine microbial strains for novel peptidic metabolites. Even though mass-spectrometric peptide detection can be performed
quite fast, true high-throughput natural product discovery approaches have still been limited by the inability to rapidly match
the identified tandem mass spectra to the gene clusters responsible for the biosynthesis of the corresponding compounds.
With Pep2Path, we introduce a software package to fully automate the peptidogenomics approach through the rapid
Bayesian probabilistic matching of mass spectra to their corresponding biosynthetic gene clusters. Detailed benchmarking of
the method shows that the approach is powerful enough to correctly identify gene clusters even in data sets that consist of
hundreds of genomes, which also makes it possible to match compounds from unsequenced organisms to closely related
biosynthetic gene clusters in other genomes. Applying Pep2Path to a data set of compounds without known biosynthesis
routes, we were able to identify candidate gene clusters for the biosynthesis of five important compounds. Notably, one of
these clusters was detected in a genome from a different subphylum of Proteobacteria than that in which the molecule had
first been identified. All in all, our approach paves the way towards high-throughput discovery of novel peptidic natural
products. Pep2Path is freely available from http://pep2path.sourceforge.net/, implemented in Python, licensed under the GNU
General Public License v3 and supported on MS Windows, Linux and Mac OS X.
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Introduction
After a steady decline at the end of the last millennium, natural
products are back in the centre of attention as leads for drug
discovery [1–4]. The secondary metabolites from which they are
derived can be categorized into various classes, according to their
chemical structures and the different ways in which they are
synthesized enzymatically. Two of the most abundant classes are
the NonRibosomally synthesized Peptides (NRPs) and Riboso-
mally-synthesized and Post-translationally-modified Peptides
(RiPPs). Many NRPs and RiPPs are of great clinical and societal
importance, having applications as antibiotics, immunosuppres-
sants or cytostatics [5].
Unlike RiPPs, NRPs are synthesized not by the ribosome but by
large enzymatic complexes called nonribosomal peptide synthe-
tases (NRPSs). These NRPSs form assembly lines of modules,
which each add one specific amino acid to the growing peptide
chain [6]. Each NRPS module normally consists of at least three
domains: a condensation (C) domain that catalyses the conden-
sation to the next amino acid, the adenylation (A) domain that
selects the amino acid to be incorporated, and the thiolation (T)
domain to which the growing peptide chain is attached. Because
they function independently of the ribosome, NRPSs can
introduce not only proteinogenic but also nonproteinogenic amino
acids into the peptides they produce. After its synthesis by NRPSs,
the core peptide scaffold of an NRP can be further modified by a
wide variety of tailoring enzymes.
For a long time, drug discovery from bioactive peptides
depended on laborious identification and characterization of one
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peptide at a time. Moreover, re-discovery of already known
peptides occurred with increasing frequency, which made the
entire process slow, inefficient and costly [7]. Conversely, the
genomic identification of biosynthetic gene clusters (BGCs) that
could potentially encode the enzymatic machinery to make novel
bioactive peptides is rapidly becoming easier, as thousands of
genomes are being sequenced each year and various algorithms
have been developed to automatically detect the BGCs that
encode NRP and RiPP biosynthesis [8–13].
Recently, a new technology, peptidogenomics, has been
introduced, which uses the potential of high-throughput mass
spectrometry (MS) [14] to dramatically speed up the discovery of
novel bioactive peptides [15]. Using this technology, short amino
acid sequence tags (which represent a part of the complete peptide)
can be reconstructed from the MS peak patterns by looking at the
mass differences between peaks of various peptidic fragments. In
turn, these ‘mass shift sequences’ can be assessed for their potential
to represent novel peptides using dereplication tools such as
iSNAP [16] and matched to BGCs predicted by methods such as
antiSMASH [10,11]. So far, the matching of mass shift sequences
to BGCs has remained a tedious and complicated procedure,
especially for NRPs. In this procedure, possible amino acid
sequences are manually compared to substrate specificity predic-
tions of NRPSs by algorithms such as NRPSPredictor2 [17], after
identification of NRPS gene clusters by antiSMASH. This lack of
automation has severely impeded high-throughput peptidoge-
nomic experimentation, and has precluded the use of peptidoge-
nomics on microbial communities with large metagenome
datasets. Moreover, the effective use of peptidogenomics on
unsequenced strains [18] also depends on the development of
computational approaches, in order to be able to compare
identified sequence tags with dozens or even hundreds of genomes
of related genome-sequenced strains to identify orthologous BGCs.
Here we fill this gap by introducing Pep2Path, a set of algorithms
that facilitate the rapid and automatic identification of candidate
BGCs that correspond to NRP- and RiPP-derived mass shift
sequence tags detected by mass spectrometry. Moreover, we show
how Pep2Path can be used to detect BGCs for previously
characterized NRPs for which the biosynthetic enzymes had not
been identified yet.
Design and Implementation
Matching nonribosomal peptide BGCs to tandem mass
spectra
The Pep2Path suite consists of two algorithms, NRP2Path for
NRPs and RiPP2Path for RiPPs. The NRP2Path algorithm has to
solve by far the more challenging problem. In order to assess how
likely it is that a given MS-derived NRP mass shift sequence
originates from a certain BGC, NRP2Path uses a Bayesian
algorithm to estimate the probability for each amino acid in the
tag to originate from each of the NRPS modules of a BGC that
encodes a certain NRPS assembly-line (Figure 1, see paragraph
below for details). Of course, sequence tags can be aligned to a
BGC-encoded NRPS assembly line in multiple ways, and BGCs
that encode multiple NRPSs may have various possible assembly-
line configurations. Hence, the final score for a match between a
BGC and a sequence tag will be the maximum score obtained for
any of the possible alignments of a sequence tag with each of the
possible assembly line orders of the NRPSs encoded by a BGC. To
help interpret cases in which multiple NRPS BGCs receive
similarly high scores, NRP2Path also calculates a colinearity index,
which measures the proportion of contiguous NRPS module pairs
that are colinear with the order of amino acids in the identified
sequence tag.
NRP2Path algorithm
Using Bayes’ Theorem, the probability P(M|A) that an NRPS
module M is responsible for the biosynthesis an observed amino
acid A in a peptide sequence tag T is:
Figure 1. Outline of the NRP2Path matching process. The input for NRP2Path consists of mass shift sequences (or amino acid search tags) on
the one hand, and genome sequences on the other hand. The latter are processed into databases by makedb, using antiSMASH and NRPSPredictor2.
When a database is queried with a mass shift sequence or amino acid search tag, Pep2Path scores all possible matches between search tags and all
possible assembly line configurations of each of the NRPS BGCs in the database.
doi:10.1371/journal.pcbi.1003822.g001
Automated Peptidogenomics with Pep2Path
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For most applications, the prior probability P(M) of a moduleM to
synthesize any observed amino acid will be the same for all
modules and can be neglected. We do note that there are scenarios
where the value of this prior probability would become relevant.
For example, if one studies peptidic compounds from a microbial
community, the abundance of the various species in the
community would largely determine P(M). In such a case, one
might estimate P(M) using the metagenomic coverage of each of
the observed species from which genome information is available.
The score S for an entire gene cluster C given a sequence tag T




ln P M DAð Þð Þ
To calculate P(M|A), the probability of an amino acid to be part
of an observed peptide P(A) is estimated using the frequencies of
amino acids in known NRPs from the NORINE database. At
those positions in a search tag that represent multiple possible
amino acids, a baseline value of (1/AA alphabet size) is used for
P(A). This is done in order not to introduce an inappropriate bias
towards matches to rare amino acids, which would otherwise lead
to high scores because the possible prior observation of such an
amino acid would erroneously be treated as an actual prior
observation. We use a pseudocount k of 1 to correct for the limited
sample size. The formula to calculate P(A), in which A represents
the NRP ‘alphabet’ considered, is:
P Að Þ~
n Að Þz k
Aj jP
A[A n Að Þzk
P(A|M) is estimated as a function of the baseline probability P(A)
and a variable IA,M, which is determined by the two types of
NRPSPredictor2 substrate specificity predictions for the A domain
in the module. Hence, the IA,M variable is an average value of two I
values: one for the support vector machine matches and one for the
Stachelhaus code matches for an NRPSmoduleM to an amino acid
A. For the Stachelhaus code predictions, the value of I corresponds
to the degree of identity of the Stachelhaus code of an NRPS
module (10 amino acids long) to that of the most closely related
knownNRPSmodule within the NRPSPredictor2 search space. For
the SVM predictions, I will be 1.0 if the amino acid in the sequence
tag matches the single amino acid prediction for the NRPS module,
0.75 if the amino acid matches the small class prediction, 0.5 if the
amino acid matches the large class prediction, 0.25 if the amino acid
matches the three-class prediction, and 0.0 if the amino acid
matches none of these. P(A|M) is calculated with the following
formula, in which c is a confidence factor (default value= 1) that
accounts for how much of the final probability is determined by the
substrate specificity predictions, as compared to the contribution by
the baseline probability P(A), and x is again a pseudo-count variable
to correct for finite sample size, this time considerably smaller than 1
(the default settings of the Pep2Path software use x=0.01):
P ADMð Þ~P Að Þzc
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Finally, we can also add an g variable that allows NRPSPre-
dictor2 mismatches to be penalized exponentially as the number of
mismatches increase:
P ADMð Þ~P Að Þzc
: IA,M





The default value in the Pep2Path software is g=2.
Combining the equations, we obtain
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Of course, sequence tags can be aligned to a BGC-encoded NRPS
assembly line in multiple ways, and BGCs that encode multiple
NRPSs may have various assembly-line configurations. Hence, the
final score for a match between a BGC and a sequence tag will be
the maximum S score obtained for any of the possible alignments
of a sequence tag with each of the possible assembly lines encoded
by a BGC.
Constructing and merging NRP2Path databases
The input of genomic data to which NRP sequence tags can be
matched proceeds through the construction of NRP2Path
databases. For this purpose, two accessory programs, makedb
and mergedb, are provided with Pep2Path. The makedb tool uses
antiSMASH2 [11] to search user-provided input sequences for
BGCs that encode NRPSs and integrates information on these
BGCs into a database. Each entry in this database consists of the
accession number or name of the nucleotide entry from which the
BGC originates, a list of genes that constitute the BGC,
taxonomic information on the species whose genome encodes
it, the modular architecture of the NRPSs within the BGC, and
substrate specificity predictions as given by the two NRPSPre-
dictor2 algorithms [17]. A database with all NRPS-containing
BGCs within the GenBank database is already provided with
Pep2Path. The mergedb tool can be used to merge this database
with custom-made databases created from locally available
sequence data, or to combine multiple custom-made databases
with one another.
Input data for NRP2Path
The input for NRP2Path is either a list of amino acids or a list of
mass shifts. In the latter case, Pep2Path converts the mass shifts
into amino acid sequence tags using the conversion table provided
by Kersten et al. [15]. Because some amino acids or amino acid
derivatives have identical masses, NRP2path will generate a list of
all possible short peptide sequences. Then, NRP2path assesses for
each of the BGCs within the selected NRP database how likely it is
that this BGC encodes the peptide from which the sequence tag
Automated Peptidogenomics with Pep2Path
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derives (Figure 1). Depending on how much is known about the
source of the biological material analyzed by MS, the user can
select a taxonomic range (strain, species, genus, etc.) within which
to search.
RiPP2Path: a simple accompanying tool to match RiPPs
to prepeptide-encoding genes
Besides matching of NRPs to their BGCs, the Pep2Path suite
also offers the ability to match RiPPs to the prepeptide-encoding
Figure 2. Quality of NRP2Path predictions with varying sequence tag lengths and NRPSPredictor2 prediction qualities. The heat map
shows the average number of correct BGC predictions for Pep2Path searches with the stendomycin sequence tag V-V-T(S)-T(S)-A-I(L)-V-G across the
Streptomyces hygroscopicus ATCC 53653 genome (20 NRPS BGCs) or across all Streptomyces nucleotide entries (342 NRPS BGCs). The searches were
done for all possible search subtags of 2–8 amino acids long, and for all combinations of 0–8 simulated mispredictions for the corresponding NRPS
modules. Mispredictions are simulated with zero scores given by Pep2Path for sequence tags matching to these domains.
doi:10.1371/journal.pcbi.1003822.g002












2 (n= 18) 75% 64% 47% 36% 26%
3 (n= 15) 78% 70% 54% 44% 37%
4 (n= 12) 83% 78% 65% 56% 45%
5 (n= 11) 90% 89% 79% 72% 61%
6 (n= 8) 96% 96% 87% 81% 74%
7 (n= 5) 99% 99% 96% 91% 88%
8 (n= 3) 100% 100% 100% 100% 100%
For each tag size, all possible search tags of that size in the test set of peptides (Table S1) were used as queries. For each BGC search space size, 50 search spaces were
generated from randomly selected BGCs from the same (sub)phylum that the NRP originates from. The resulting percentages represent the average number of cases in
which the correct BGC ended up as the (shared) best hit across all possible sequence tags and across all possible search space permutations. Shared best hits were
included because of the frequent presence of orthologous BGCs encoding the same molecule in related genomes. The n in the left column signifies the number of test
peptides large enough to be included in the analysis for this tag size; from each of these test peptides, all possible subtags were used in cases where the length of the
tag is shorter than the length of the peptide.
doi:10.1371/journal.pcbi.1003822.t001
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genes that encode their primary sequences, similar to the matching
module from the recently launched RiPPquest [19]. This is done
by the RiPP2Path algorithm. Like NRP2Path, RiPP2Path uses a
dedicated translation table to convert an identified mass shift
sequence into all possible amino acid sequences that it could
represent. To match these possible RiPP amino acid sequences to
genomically encoded precursor peptides, it then reads in a set of
(meta)genomic sequences and retrieves their six translation frames.
Finally, it performs a simple matching of each possible RiPP
sequence to the translation frames, using a sliding window with a
word size equal to the tag length. The key difference between the
RiPPquest and RiPP2Path algorithms is that RiPPquest (in its
current version) is specifically aimed at lanthipeptides, while
RiPP2Path can identify prepeptides of any type: hence, RiPPquest
will be better suited to search for lanthipeptides in a large number
of genomes, while RiPP2Path will be the method of choice for
discovering other (and novel) types of RiPPs. Also, unlike
RiPPquest, which uses molecular networking to locate matches
to a database, RiPP2Path directly uses mass shift or amino acid
sequences as input.
Results
Benchmarking shows that NRP2Path is powerful and
robust
As a first assessment of how NRP2Path would confront the
difficult challenge to match NRP-derived mass shift sequences to
BGCs, we tested whether it would be successful in matching the V-
V-T(S)-T(S)-A-I(L)-V-G sequence tag that was used to identify the
BGC of the nonribosomal peptide stendomycin by Kersten et al.
[15]. Pep2Path appeared to do this very effectively: even when the
search space consisted of all 12,470 NRPS BGCs in the GenBank
database, the stendomycin BGC emerged as the top hit. By
varying the sequence tag size between 2 and 8 and introducing 0–
8 simulated mispredicted substrate specificities (by artificially
setting the score for a query amino acid to zero) for the
Table 2. Novel matches of NORINE-derived NRPs to BGCs detected in genome sequences.
Compound Reference Species (accession nr.) Locus tags




















































Candidate BGCs for trichotoxin, ferintoic acid, plusbacin and amphibactin B were discovered by searching within the taxonomic range of the species in which the
molecules were found. The candidate BGC for tripropeptin A was discovered by searching the entire Pep2Path database.
doi:10.1371/journal.pcbi.1003822.t002
Table 3. Matching of mass sequence tags to RiPP gene clusters using RiPP2Path.
Peptide Search tag Genome Matches in genome
SSV-2083 I(L)GA(C)GTA(C)WI(L)A(C)V Streptomyces sviceus ATCC 20983 1
SGR-1832 AVAQ(K)FVI(L)Q(K)GSTI(L) Streptomyces griseus IFO 13350 1
SCO-2138 VHFVGWI(L) Streptomyces coelicolor A3(2) 1
SLI-2138 GI(L)VHFVGWI(L) Streptomyces lividans TK24 1
SWA-2138 I(L)AGI(L)VHFI(L)GWI(L) Streptomyces sp. E14 (WASP) 1
SRO15-2005 YWSRRI(L)I(L) Streptomyces roseosporus NRRL 15998 1
SRO15-2212 VVI(L)S(C)T Streptomyces roseosporus NRRL 15998 47
SRO15-3108 AS(C)ATVTI(L) Streptomyces roseosporus NRRL 15998 1
SAL-2242 VTI(L)S(C)T Streptomyces albus J1074 39
Seven out of the nine search tags resulted in unique matches in their corresponding Streptomyces genomes.
doi:10.1371/journal.pcbi.1003822.t003
Automated Peptidogenomics with Pep2Path
PLOS Computational Biology | www.ploscompbiol.org 5 September 2014 | Volume 10 | Issue 9 | e1003822
corresponding stendomycin NRPS modules, we show that also
BGCs with less accurate NRPSPredictor2 predictions (i.e., with up
to one or two completely wrong predictions) can be identified
robustly within a genome or species, even with relatively small
sequence tags (Figure 2).
NRP2Path benchmarking on 18 NRPs of known structure
To investigate how well NRP2Path would work in practice on
novel compounds, we mined 18 NRPs from the recent scientific
literature, together with their corresponding NRPS BGCs (Table
S1). None of these had yet been incorporated into the
NRPSPredictor2 training sets. In order to assess how well
Pep2Path would be able to match tags from these NRPs to the
correct BGCs under varying conditions, we varied the sequence
tag size from 2 to 8 and tested all possible search tags of these sizes
on databases with sizes ranging from 5 NRPS BGCs to 100 NRPS
BGCs (an average bacterial genome contains ,5 NRPS BGCs).
For each database size, 50 randomly permuted BGC databases
were created from BGCs originating from genomes within the
same (sub)phylum, and the results were averaged across all of these
permutations. The results (Table 1) confirm that the minimum
sequence tag size to confidently match an NRP to a BGC is
around 2–4 when the genome sequence is known. When the
search space is larger, a situation that represents the mining of
unsequenced strains for NRPs and attempting to match them to
orthologous BGCs within the same genus [18], larger sequence
tags (e.g., 5–8 amino acids long) are often still sufficient to identify
the correct BGC.
New gene clusters for old molecules: an application
Finally, we used NRP2Path in an effort to find BGCs for NRPs
within the NORINE database [20] for which no BGC had been
discovered so far. Intriguingly, we discovered novel candidate
BGCs for four molecules by searching all NRPS BGCs from the
species from which the compound had originally been isolated
(Table 2). When we expanded the search space to screen the
entire database, we discovered another very good match, for
tripropeptin A (Table 2). Surprisingly, although this eight-amino-
acids-long peptide was originally discovered in the gamma-
proteobacterium Lysobacter sp. [21], we found a match with a
BGC in the genome of the beta-proteobacterium Collimonas
fungivorans Ter33 (Figure S1). The tripropeptins are highly
important molecules from a pharmaceutical point of view, as
tripropeptin B and C display potent antibacterial activity against
methicillin-resistant Staphylococcus aureus (MRSA), vancomycin-
resistant enterococci (VRE), and penicillin-resistant Streptococcus
pneumoniae [22,23]. All in all, the results of the NORINE searches
show how even in the absence of new peptidogenomic data
Pep2Path can identify putative genomic loci that encode the
biosynthesis of important molecules, opening up new possibilities
to further engineer these pathways and/or produce the com-
pounds in high titers through metabolic engineering or heterol-
ogous expression.
RiPP2Path is able to specifically detect RiPP prepeptides
in the majority of cases
When testing RiPP2Path on the nine Streptomyces RiPPs
identified by Kersten et al. [15], seven of these produced unique
matches of their search tags to the corresponding genome
sequences (Table 3). The remaining two search tags could still
be manually matched to gene clusters based on the antiSMASH-
based identification of RiPP BGCs containing RiPP2Path
matches.
Availability and Future Directions
Pep2Path is freely available from http://pep2path.
sourceforge.net/, implemented in Python, licensed under the
GNU General Public License v3 and supported on MS
Windows, Linux and Mac OS X. To maximize the convenience
for the majority of experimental scientists in using a new
computational method, it is often helpful to provide a user-
friendly web-server with accompanying step-by-step protocols
for standard analytical scenarios. Providing these for the
Pep2Path tools is one of the remaining challenges for future
development of the software.
All in all, the automated peptidogenomics technology offered
by Pep2Path constitutes a radical departure from the one-
molecule-per-study approach to drug discovery from natural
products that has dominated the field for long. The combination
of the rapid sampling of chemical space by tandem mass
spectrometry with effective computational matching of the
chemistry to BGCs will allow quick identification and dereplica-
tion of large numbers of novel peptides. While detailed structural
characterization of the hits for now remains a bottleneck, new
methods are appearing that will accelerate this process as well
[24]. For now, identified peptides can be prioritized for further
detailed characterization based on the biosynthetic novelty
inferred from the BGC architecture, combined with phenotypic
assays.
With nanoDESI mass-spectrometry [25], automated peptido-
genomics also allows genome mining directly from environmental
samples, without strain isolation or genome sequencing: the
identified peptides can be matched directly to gene clusters in the
rapidly growing database of already sequenced genomes [18].
When combined with large-scale metagenomics, automated
peptidogenomics will also make it possible to sample NRPs in
environmental samples at large scales, by integrating mass spectral
molecular networks [26,27] from MS data with BGC similarity
networks [28], and cross-linking these two network types with a
third type of networks that represent Pep2Path matching scores
between molecule families and gene cluster families.
The key limitation of Pep2Path is that the quality of its results
depends on the accuracy of the substrate specificity predictions by
NRPSPredictor2. For some organisms, particularly fungi, the
training data for these predictions is currently still limited, which
leads to a decrease in predictive power. Hence, we will strive to
continuously update the dataset of experimentally verified NRPS
adenylation domain substrate specificities according to rigorous
data standards, in order to keep improving the power of
approaches such as Pep2Path as knowledge progresses.
The approach described here can potentially be extended to
other compound classes, such as saccharides [29], once an
automated system for the detection of sugar biosynthesis genes
and prediction of glycosyltransferase substrate specificities has
been set up. Hence, Pep2Path paves the way for the high-
throughput characterization of the vast universe of BGCs
discovered in genomic data of organisms throughout the tree of
life.
Supporting Information
Code S1 Source code and test data. Full source code of
Pep2Path version 1.1.0 and associated test data that allow users to
test the functionality of the software. Updated versions of the
Pep2Path code will be made available on http://pep2path.
sourceforge.net in the future.
(GZ)
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Figure S1 Gene cluster and predicted possible biosyn-
thetic scheme for the production of tripropeptin-like
molecules by Collimonas fungivorans Ter331. The gene
cluster was identified by Pep2Path based on the raw amino acid
sequence of compounds originally purified from Lysobacter sp.
BMK333-48F3. The outline of the gene cluster and its encoded
NRPS assembly-line above shows that the architecture of the gene
cluster is consistent with the chemical structure of molecules highly
similar to the tripropeptins that have been identified in Lysobacter.
This BGC has eight NRPS modules, of which seven gave
NRPSPredictor2 predictions exactly matching the tripropeptin A
sequence in the right order, while the eighth prediction was only a
near miss (ornithine predicted instead of arginine). This indicates
that such a gene cluster might have undergone horizontal gene
transfer at least once, from one subphylum to another. The
peptides actually produced by Collimonas might have small
differences in chemistry, compared to the Lysobacter tripropeptins,
due to slight variations and/or promiscuity in the tailoring
reactions and substrate acceptance.
(PDF)
Table S1 NRP2Path benchmarking dataset. The table
displays 18 recently experimentally characterized NRPs and their
biosynthetic gene clusters used for benchmarking NRP2Path. Rare
amino acids that are not covered by the Pep2Path translation table
are marked as ‘Xxx’.
(PDF)
Text S1 Pep2Path documentation. Full documentation for
the Pep2Path software, including installation instructions, infor-
mation on general use, instructions on command-line usage and
the software license.
(PDF)
Text S2 Pep2Path test data documentation. Description of
the comprehensive set of test data that showcases the Pep2Path
software. This includes instructions for testing NRP2Path using the
stendomycin sequence tag and the set of 18 recently discovered
NRPs mentioned in the manuscript text, as well as instructions for
testing RiPP2Path using the set of nine recently discovered RiPPs.
(PDF)
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